TTNP Titan Pharmaceuticals Inc

Titan Pharmaceuticals Inc is a specialty pharmaceutical company. The company is primarily engaged in the development of pharmaceutical products.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/18/1996
Outstanding shares:  9,914,158
Average volume:  99,883
Market cap:   $12,491,839
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    888314606
ISIN:        US8883146065
Valuation   (See tab for details)
PE ratio:   -1.43
PB ratio:   1.68
PS ratio:   5.10
Return on equity:   -82.99%
Net income %:   -254.12%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy